Partnering and M&A Yearbook

Yearbook 2012

Provides comprehensive understanding and unprecedented access to the partnering and M&A deals and agreements entered into by the worlds leading healthcare companies during 2011.

Bioinformatics Partnering Terms and Agreements

Provides comprehensive insight into bioinformatics partnering deals and agreements entered into by leading healthcare companies.

Vaccine Partnering Terms and Agreements

Provides detailed understanding and analysis of how and why companies enter vaccine partnering deals, plus access to actual vaccine agreements

Provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Preparing Health Technology Submissions for Pharmaceutical Products

Meeting Formulary Submission Requirements for New Product Assessments and Disease Area & Therapeutic Class Reviews

Considers how manufacturers should respond to emerging evidentiary and analytical standards

Directory of Business Development & Licensing Contacts 2006

The Worldwide Pharmaceutical Industry

Over 1,300 business development opportunities listed...

Health Economics in the Drug Life Cycle

Achieving success in drug discovery, development, reimbursement and marketing

A 75,000 word report from Urch Publishing identifies the clusters of health economic activities which should accompany drug development from discovery through to marketing approval and then market reimbursement, market entry and the support of the product through the product life cycle.

Little Black Book of Pharma Marketing, The

eDetailing - A Strategic Analysis of Implementation and ROI

Comprehensive insight into eDetailing including regulations, technologies, companies and strategic recommendations.

Customer Driven Pharmaceutical Marketing

Developing & exploiting profitable relationship

Tackles the new paradigm and argues that companies should focus on the end user more than ever and build long term relationships.

Patient Groups and the Global Pharmaceutical Industry

Patient advocacy groups have emerged as a key customer for the industry as they potentially hold a great deal of power and influence. Such 'added value' approaches are becoming common-place and the advent of abundant and well run patient advocacy groups has placed such company-patient group alliances to the top of the strategy agenda

Successful Licensing

Negotiating & Drafting Optimum Pharmaceutical Deals

This report provides a comprehensive guide to the business development processes involved in assessing product opportunities, negotiating deals and implementing crucial partnerships.